Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
19.4M
-
Shares change
-
-3.32M
-
Total reported value, excl. options
-
$14.7M
-
Value change
-
-$2.56M
-
Put/Call ratio
-
0
-
Number of buys
-
9
-
Number of sells
-
-24
-
Price
-
$0.76
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q4 2022
48 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q4 2022.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.4M shares
of 144M outstanding shares and own 13.47% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (4.78M shares), ORBIMED ADVISORS LLC (3.05M shares), FMR LLC (2.97M shares), Knoll Capital Management, LLC (2.45M shares), Alyeska Investment Group, L.P. (1.27M shares), VANGUARD GROUP INC (797K shares), Point72 Asset Management, L.P. (720K shares), Rock Springs Capital Management LP (597K shares), Artal Group S.A. (400K shares), and GEODE CAPITAL MANAGEMENT, LLC (361K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.